Two Major Exhibitions, One Global Vision
In May 2025, Medconn participated in two major international exhibitions in the IVD industry:
- WorldLab Euromedlab — Brussels, Belgium
- Hospitalar — São Paulo, Brazil
As major events for the global medical laboratory, clinical diagnostics, and in vitro diagnostics industries, both exhibitions brought together leading IVD companies, healthcare professionals, and industry experts from around the world. They provided an important platform for showcasing technological innovation, exploring international partnerships, and discussing the latest developments and trends shaping the future of IVD.
Flagship HbA1c Solutions Take Center Stage
At both exhibitions, Medconn showcased its flagship MQ Series HbA1c Analyzers.
Featuring accurate and stable HbA1c testing capabilities, together with hemoglobin variant and thalassemia testing modes, the MQ Series has been widely adopted across a range of clinical applications in both domestic and international markets.
Fully Automated Hematology Analyzer Makes Global Debut
Since its first international appearance at Medlab Middle East in Dubai in early 2025, Medconn's fully automated hematology analyzer has attracted growing attention from the global IVD community.
Its simultaneous showcase in Brussels and São Paulo marked another important step in bringing this innovative solution to international markets.
Powered by nucleic acid fluorescence staining technology, the analyzer delivers accurate 5-part differential hematology testing and supports key parameters including IG and NRBC. It also features malaria and dengue risk alerts, providing clinicians and laboratories with additional support for infectious disease screening and assessment.
Global Recognition for Chinese Innovation
During the Brussels exhibition, Prof. Song Haibo, Vice President of the National Association of Health Industry Enterprise Management, President of its Medical Laboratory Industry Branch, Deputy Director of the Shanghai Institute of Laboratory Medicine, Director of the Institute for IVD Industry Development, and Founder of CACLP, together with Prof. Wang Hualiang, Director of the Shanghai Institute of Laboratory Medicine, Chairman of the Experimental Medicine Branch of the National Association of Health Industry Enterprise Management, and Editor-in-Chief of VIEW, visited the Medconn booth and offered their guidance and support.
2025 marks an important year in Medconn's global expansion. Through its participation in WorldLab Euromedlab and Hospitalar, Medconn not only demonstrated its technological capabilities and product innovation but also showcased the growing strength of Chinese innovation and manufacturing on the global IVD stage.
In 2025 and beyond, Medconn remains committed to advancing in vitro diagnostics and contributing to better health worldwide. Together with global partners, Medconn looks forward to creating new possibilities for the future of medical diagnostics.
